We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

LIEN:NASDAQChicago Atlantic BDC, Inc. Analysis

Data as of 2026-05-25 - not real-time

$9.89

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Chicago Atlantic BDC (LIEN) posted a quarterly EPS of $0.44, beating the consensus estimate by 22% and turning a loss year‑over‑year into profit. The company’s revenue surged 40% YoY to $59.1 M, supporting a robust profit margin of 58% and a forward EPS of $1.68. At a trailing P/E of 6.6 versus the industry average of 16.8, the stock trades at a steep discount, while the price‑to‑book of 0.74 is well below its book value of $13.30 per share. A DCF fair value near $39 implies a potential upside of more than 300% relative to the current price of $9.89. However, the balance sheet carries $54.5 M of debt against just $3.3 M of cash, yielding a debt‑to‑equity ratio of 17.9 and a high payout ratio of 91%, raising concerns about dividend sustainability. The stock offers an eye‑catching dividend yield of 13.8%, but operating cash flow is negative ($‑34 M), indicating the dividend is largely funded by external financing.
Technically, the price sits above the 20‑day (9.44) and 50‑day (9.50) moving averages and the MACD histogram is positive, signaling short‑term bullish momentum. RSI at 60.8 suggests the stock is not yet overbought, and volume is trending upward, supporting the recent price gains. Despite the bullish short‑term indicators, the 200‑day average (10.25) remains above price and the computed trend direction is bearish, reflecting longer‑term weakness. Volatility is high at 32% over the past 30 days, while beta 0.18 indicates price swings are largely independent of the broader market. The company operates in the cannabis‑adjacent BDC space, exposing it to medium‑high regulatory risk as policy changes could impact loan performance. Overall, the stock appears undervalued with strong near‑term catalysts but faces significant leverage and dividend‑sustainability headwinds that temper longer‑term optimism.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 8/10

Key Factors

  • Quarterly earnings beat and strong revenue growth
  • Bullish MACD and price above short‑term SMAs
  • Increasing volume supporting momentum

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • High dividend yield but sustainability concerns
  • Elevated leverage and debt‑to‑equity ratio
  • Medium‑high regulatory risk in cannabis sector

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Potential upside from valuation gap
  • Long‑term bearish trend and 200‑day average above price
  • Continued regulatory and leverage uncertainties

Key Metrics & Analysis

Financial Health

Revenue Growth40.10%
Profit Margin57.89%
P/E Ratio6.6
ROE11.30%
ROA6.52%
Debt/Equity17.92
P/B Ratio0.7
Op. Cash Flow$-34042844
Free Cash Flow$26.6M
Industry P/E16.8

Technical Analysis

TrendBearish
RSI60.8
Support$8.92
Resistance$10.25
MA 20$9.44
MA 50$9.50
MA 200$10.25
MACDBullish
VolumeIncreasing
Fear & Greed Index91.61

Valuation

Fair Value$39.20
Target Price$11.00
Upside/Downside11.22%
GradeUndervalued
TypeBlend
Dividend Yield13.77%

Risk Assessment

Beta0.18
Volatility32.22%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.